During the development of breast cancer, the capacity of proliferation (23.68% for MCF-7 and 17.24% for HCC1937), explained by the deregulation of leptin in obesity, could be very relevant at the moment of prescribing a treatment to the patient. Here, LEP is linked to breast carcinoma.